Clinical Manifestations of COVID-19 Patients with Comorbid and Non-comorbid at Dr. Soetomo Hospital, Surabaya


  • Erika Martining Wardani Departemen of Nursing, Faculty of Nursing and Midwifery, Universitas Nahdlatul Ulama Surabaya, East Java, Indonesia
  • Riezky Faisal Nugroho Departemen of Nutrition, Politeknik Kesehatan Kemenkes Surabaya, Surabaya, East Java, Indonesia
  • Difran Nobel Bistara Departemen of Nursing, Faculty of Nursing and Midwifery, Universitas Nahdlatul Ulama Surabaya, East Java, Indonesia
  • Raden Khairiyatul Afiyah Departemen of Nursing, Faculty of Nursing and Midwifery, Universitas Nahdlatul Ulama Surabaya, East Java, Indonesia; Department of Public Health, Faculty of Public Health, Universitas Airlangga, Mulyorejo, Surabaya, East Java, Indonesia
  • Siti Nur Hasina Departemen of Nursing, Faculty of Nursing and Midwifery, Universitas Nahdlatul Ulama Surabaya, East Java, Indonesia
  • Yurike Septianingrum Departemen of Nursing, Faculty of Nursing and Midwifery, Universitas Nahdlatul Ulama Surabaya, East Java, Indonesia



Clinical manifestation, COVID-19, Comorbid, Length of treatment


Background : Covid-19 has been declared a global health emergency. Reports of thousands of cases with morbidity and mortality continue to increase every day. The clinical course of patients with comorbidities influences the prognosis and progression of the covid-19 disease. Hypertension is the most common cormorbidity of covid-19 patients with long hospitalizations.

Objective : This study aimed to determine the clinical differences between covid-19 patients cormobid and non cormobid .

Methods : The study was conducted retrospectively through samples of medical records of inpatients for the period June 1, 2021 – August 31, 2021. The samples were divided into comorbid and non-cormobid groups; each totaling 130 medical records. The sample of the comorbid group was selected by simple random; while the non-cormobid group with the matching process. Data were analyzed using t-test and Wilcoxon.

Results : The most common kormobid is hypertension with clinical manifestations of cough, fever, headache, runny nose, painful swallowing, anosmia, shortness of breath, nausea, vomiting and diarrhea. The average length of stay for patients with comorbidities was 21 days and without comorbidities 14 days. The test results showed that there were clinical differences between patients with comorbid and non-cormobid patients with p value = 0.0000 (p>0.05) and there was a difference in length of stay with p-value = 0.001 (p>0.05).

Conclusion : The clinical difference between covid-19 patients comorbid and non cormobid lies in the symptoms of headache with a longer duration of treatment, which is 22 days. More intensive treatment and care is needed for covid-19 patients with comorbid hypertension.

Keywords : clinical manifestation; covid-19; comorbid; length of treatment.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Ali AS, Baloch M, Ahmed N, Arshad Ali A, Iqbal A. The outbreak of coronavirus disease 2019 (COVID-19-an emerging global health threat. J Infect Public Health. 2020;13(4):644-6. PMid:32199792 DOI:

Hong Y, Wu X, Qu J, Gao Y, Chen H, Zhang Z. Clinical characteristics of coronavirus disease 2019 and development of a prediction model for prolonged hospital length of stay. Ann Transl Med. 2020;8(7):443-3. PMid:32395487 DOI:

Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Carl CA, et al. COVID-19 length of hospital stay: A systematic review and data synthesis. BMC Med. 2020;18(1):270. PMid:32878619 DOI:

Wu S, Xue L, Legido-Quigley H, Khan M, Wu H, Peng X, et al. Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital. PLoS One. 2020;15:1-14. PMid:33085709 DOI:

Hamid H, Abid Z, Amir A, Rehman TU, Akram W, Mehboob T. Current burden on healthcare systems in low-and middle-income countries: Recommendations for emergency care of COVID-19. Drugs Ther Perspect. 2020;36(10):466-8. PMid:32837195 DOI:

World Health Organization. COVID-19 Weekly Epidemiological Update, 27 December 2020. Geneva: World Health Organization; 2020a.

Pemerintah Kota Surabaya. Surabaya Tanggap COVID-19; 2020. Available from: [Last accessed on 2020 Jul].

Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020;25(10):2000180. PMid:32183930 DOI:

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239. PMid:32091533 DOI:

Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: A structured literature review. Infection. 2021;49(1):15-28. PMid:32860214 DOI:

Han J, Shi LX, Xie Y, Zhang YJ, Huang SP, Li JG, et al. Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration. Epidemiol Infect. 2020;148:e125. PMid:32580792 DOI:

Yang J, Zheng Y, Gou X, Pu K, Chen Z. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5. PMid:32173574 DOI:

Tascioglu D, Yalta K, Yetkin E. Hypertension and diabetes mellitus in patients with COVID 19: A viewpoint on mortality. Cardiovasc Endocrinol Metab. 2020;9(3):108-9. PMid:32803144 DOI:

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. DOI:

Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020;127:104354. DOI:

Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis. J Infect. 2020;81(1):e84-6. DOI:

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. PMid:32031570 DOI:

Grace C. Manifestasi klinis dan perjalanan penyakit pada pasien covid-19. Med J Lampung Univ. 2020;9(1):49-55.

Lapostolle F, Schneider E, Vianu I, Dollet G, Roche B, Berdah J, et al. Clinical features of 1487 COVID-19 patients with outpatient management in the greater paris: The COVID-call study. Intern Emerg Med. 2020:15(5):813-7. PMid:32474850 DOI:

Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, et al. Coronavirus diseases (COVID-19) current status and future perspectives : A narrative review. Int J Environ Res Public Health. 2020;17(2690), 1–11. PMid:32295188 DOI:

Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med. 2020;35(5):1545-9. PMid:32133578 DOI:

Susilawati S, Falefi R, Purwoko A. Impact of COVID-19’s pandemic on the economy of Indonesia. Budapest Int Res Crit Inst. 2020;3(2):1147-56. DOI:

Thai PQ, Toan DT, Dinh TS, Van Hoang TH, Luu NM, Hung LX, et al. Factors associated with the duration of hospitalization among COVID-19 patients in Vietnam: A survival analysis. Epidemiol Infect. 2020;148:e114. PMid:32517822 DOI:




How to Cite

Wardani EM, Nugroho RF, Bistara DN, Afiyah RK, Hasina SN, Septianingrum Y. Clinical Manifestations of COVID-19 Patients with Comorbid and Non-comorbid at Dr. Soetomo Hospital, Surabaya. Open Access Maced J Med Sci [Internet]. 2022 Apr. 14 [cited 2024 Jun. 17];10(G):330-4. Available from:



Nursing in Internal Medicine


Most read articles by the same author(s)

1 2 3 > >>